孔源性视网膜脱离合并脉络膜脱离眼的玻璃体蛋白质组
本文系统综述2000年1月至2023年12月间关于孔源性视网膜脱离合并脉络膜脱离(RRD-CD)患眼玻璃体分析的英文原始文献,共纳入7项研究。玻璃体分子按上调与下调状态分类,补体级联(C3a和C5a)、免疫反应(sICAM-1、IL-1B及细胞代谢物)和主要炎症介质(MIF和IL-6)存在显著失调,可能作为治疗靶点。玻璃体内及全身药物治疗RRD-CD效果不一,现有手段及靶向新因子的应用尚未充分评估,需进一步研究。
要点
- 补体级联(C3a和C5a)、免疫反应(sICAM-1、IL-1B及细胞代谢物)和主要炎症介质(MIF和IL-6)在RRD-CD患眼玻璃体中显著失调。
- 玻璃体内及全身药物治疗RRD-CD的效果不一。
- 现有治疗手段及靶向新因子的应用在RRD-CD中尚未充分评估,需进一步研究。
核心结论
- RRD-CD患眼玻璃体蛋白水平较对照发生变化,凸显了疾病病理生理机制。
- 存在临床靶点,需进一步研究以改善该病的管理。
研究设计与样本
- 系统综述,检索2000年1月至2023年12月英文原始文献,纳入7项符合标准的研究。
- 玻璃体分子按RRD-CD眼较对照上调或下调分类,系统评估细胞因子、趋化因子、生长因子、代谢物、转运分子及其他血浆蛋白/脂质以识别病理生理过程。
主要发现
- 质谱和免疫分析是最常用的评估方法。
- RRD-CD眼玻璃体中补体级联(C3a和C5a)、免疫反应(sICAM-1、IL-1B及细胞代谢物)和主要炎症介质(MIF和IL-6)存在显著失调,可能作为突出靶点。
- 玻璃体内及全身药物治疗RRD-CD的效果不一。
- 现有治疗手段及靶向新因子的应用在RRD-CD中尚未充分评估。
局限性
- 原文结论指出需进一步研究以改善该病的管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To review the literature on vitreous analysis in eyes with concurrent rhegmatogenous retinal and choroidal detachment (RRD-CD). METHODS: A comprehensive literature search was performed from January 2000 through December 2023 for "rhegmatogenous retinal detachment", "choroidal detachment", AND "vitreous." All English language primary literature was reviewed, and seven studies were found to meet inclusion criteria. Vitreous molecules were categorized by upregulated and downregulated states in RRD-CD eyes compared to controls. The cytokines, chemokines, growth-factors, metabolites, transporter molecules, and other plasma proteins/lipids in the vitreous samples were evaluated in a systematic format to identify pathophysiologic processes involved. RESULTS: Mass spectrometry and immunoassays were most commonly employed for evaluation. Notable dysregulation of the complement cascade (C3a and C5a), immunologic response (sICAM-1, IL-1B, and cellular metabolites), and major inflammatory mediators (MIF and IL-6) was identified and may serve as salient targets. Intravitreal and systemic agents have had mixed success in treating RRD-CD. Utilization of existing modalities and targeting novel factors have not been fully evaluated in RRD-CD. CONCLUSIONS: Identification of alterations in levels of vitreous proteins in RRD-CD cases compared to controls highlights disease pathophysiology. Clinical targets exist and additional studies are warranted to improve management of this condition.
引用
- Patel NR, Brucker AJ, Kolomeyer AM, et al. Vitreous Proteome in Combined Rhegmatogenous Retinal and Choroidal Detachment. Retina. 2025. PMID: 40577623. doi:10.1097/IAE.0000000000004565
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。